close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Direxion Daily S&P Biotech Bull 3X Shares (NY:LABU)

131.46 +3.21 (+2.50%)
Streaming Delayed Price Updated: 10:03 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Direxion Daily S&P Biotech Bull 3X Shares

SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval
Via Stocktwits
Can These 5 Assets Skyrocket Your Portfolio?
Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look. 
Via Talk Markets
Topics ETFs Stocks
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks
Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment. 
Via Benzinga
Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win
Wall Street piled up strong gains in yesterday’s trading session, with the S&P 500 hitting the 25th record high this year and the Nasdaq Composite Index touching another record. 
Via Talk Markets
Topics ETFs Stocks
Sector Rotation
In this video, I discuss sector rotation out of technology stocks and into consumer staple, energy, and bank stocks. 
Via Talk Markets
The 3 Best Leveraged ETFs for April 2024
If you want to speculate on baskets of securities, then these best leveraged ETFs for April could be what the doctor ordered. 
Via InvestorPlace
Topics ETFs
5 Best-Performing Leveraged ETFs Of February
U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Amid this environment, here are some of the best-performing leveraged... 
Via Talk Markets
Topics ETFs Stocks
Stocks To Watch This Week - Sunday, Feb. 11
This week, we take a look at small-cap and mid-cap stocks by using ETFs such as MDY and the leveraged ETF TNA. We also like the look of the LABU ETF. 
Via Talk Markets
Topics ETFs
Want Diversified Upside in Biotechnology? Check out LABU
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. 
Via MarketBeat
Topics ETFs Stocks
The Week Ahead Commentary - Saturday, Feb. 4
Robert Desmond looks at ETF and individual equities for the week just ended and gives his take on trading for the week to come. 
Via Talk Markets
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing. 
Via Talk Markets
3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty
Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine. 
Via InvestorPlace
The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)…
China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing. 
Via Talk Markets
3 Biotech Stocks to Buy That Are Under Severe Pressure
The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom. 
Via InvestorPlace
5 Best Leveraged ETFs of Last Week
The S&P 500 hit a record close last week, courtesy of a Santa Clause rally. Wall Street was charged-up with the S&P 500 (up 1.22%), the Dow Jones (up 0.15%), the Nasdaq Composite (up 3.12%) and the... 
Via Talk Markets
5 Best-Performing Leveraged ETFs of August
Here are some best-performing leveraged equity ETFs from different corners of the market that gained in double digits in August. 
Via Talk Markets
The Week In Charts: Figure This Out And You’ll Own The World
A discussion on trading hot IPOs and some of the issues that have arisen in recent times. 
Via Talk Markets
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
A look at lessons learned from active trading of IPOs, ETFs, Russian Dolls, and a discussion on what might be the secret to trading-which ironically, is the polar opposite to trading. 
Via Talk Markets
The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading
A look at lessons learned from active trading including what might be the secret to trading-which ironically is the polar opposite to trading. 
Via Talk Markets
These Were The Stocks David Green Discussed On His Show This Morning
David Green made money day trading Bridgeline Digital Inc (NASDAQ: 
Via Benzinga
The Week In Charts-Volatility: Rabbit Hole Or Holy Grail?
A revisit using volatility to let us know when the elusive 
Via Talk Markets
A Biotech ETF For Aggressive, Risk-Tolerant Investors
The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) seeks the daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Index for a single day. 
Via Talk Markets
Topics Stocks
A Biotech ETF For Aggressive, Risk-Tolerant Investors
The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQ: BIIB). The FDA approved its controverisal drug that can treat Alzheimer’s Disease. Not... 
Via Benzinga
CrowdStrike Stock Earnings Trade
In this video, we review the CrowdStrike stock earnings trade. We also review our top five stocks for the new trading week. 
Via Talk Markets
This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming
Humanigen Inc. (NASDAQ: HGEN) shares made gains Wednesday following the publication of results from a Phase 3 randomized double-blind placebo-controlled study. The... 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today